Volltext-Downloads (blau) und Frontdoor-Views (grau)
The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 1 of 3
Back to Result List

Conception and implementation of a market analysis for the pharmaceutical industry and its production locations in Asia, on the example of China.

  • China’s increasing importance in the pharmaceutical industry has attractedthe attention of the mechanical engineer for packaging machinery, Christ Packing Systems. Issues in entering the market have raised questions about the understanding of target customers in China and how the distribution system works. An in-depth understanding of the Chinese pharmaceutical market allows Christ Packing Systems to successfully approach the market.Based on interviews with experts in the field, industry reports and strategic analysis, this research paperwill provide insights into the pharmaceutical industry in China and its challenges and opportunities for Christ Packing Systems. Results show that pharmaceutical companies and their suppliers have to cope withgreat uncertainty. The involvement of the Chinese government stimulates the development of more and more innovative manufacturers of brand medicine. Drastically reducing prices for medicineand making them affordable for everyone in Chinais one of the governments’big goals. After supply shortages of critical medicines during the Covid-19 crisis, China has to expect that foreign groups will move some of their production closer to their customers in Europe and the United States. On the other hand, China is one of the most attractive marketsfor pharmaceutical companies. The largest population of the world which is ageingand increasingly suffers from chronic diseases, demands high quantities of medicine. Adding to that, the growing middle class and an improved healthcare system enables more and more people in China to afford and have access to pharmaceuticals. With this great market potential, Christ Packing Systems is advised to further pursue and intensify its market expansion to China. There are several alternatives to successfully enter the market while keeping the risks and costs at a reasonable level.

Export metadata

Additional Services

Search Google Scholar

Statistics

frontdoor_oas
Metadaten
Author:Lilli Häberlin
Advisor:Paul Taylor
Document Type:Bachelor Thesis
Language:English
Year of Completion:2020
Granting Institution:Hochschule Furtwangen
Release Date:2020/12/09
Tag:China; Market analysis; Pharmaceutical industry
Degree Program:IBM - International Business Management
Functional area:Marketing
Licence (German):License LogoUrheberrechtlich geschützt